A Brighter Future for Autism Care: Global Orthopedic Braces and Support Market
... View MoreA Brighter Future for Autism Care: Global Orthopedic Braces and Support Market
The global orthopedic braces and supports market is on track for significant growth, with a projected value of US$8.8 billion by 2034. This upward trend represents a compound annual growth rate (CAGR) of 6.7% from 2024, reflecting the increasing demand for these supportive solutions in managing musculoskeletal conditions and enhancing mobility.
Orthopedic braces and supports offer a wide range of benefits, including pain relief, improved joint stability, and support during recovery from injuries. They play a crucial role in various applications, from post-surgical rehabilitation to chronic pain management and sports injury prevention.
Explore With Your Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12207
Here are some key drivers propelling the market growth:
Rising Prevalence of Musculoskeletal Disorders: The global aging population and increasingly active lifestyles are leading to a higher incidence of musculoskeletal disorders like arthritis, osteoporosis, and sports injuries.
Focus on Non-Invasive Treatment Options: Healthcare providers are increasingly recommending non-invasive solutions for managing musculoskeletal conditions whenever possible. Orthopedic braces and supports offer an effective and non-invasive approach.
Technological Advancements: Continuous advancements in materials science and design are leading to the development of more comfortable, lightweight, and user-friendly orthopedic braces and supports.
Top Recommended Strategies to Stay Ahead of Market Competition:
Key players can use smart sensors, materials, and biofeedback mechanisms to provide rehabilitation experiences and personalized support for effective rehabilitation bracing solutions.
Companies need to prioritize research to develop new materials, applications, and designs for braces and support to effectively meet the needs of patients and align with emerging trends.
Industry participants can consider collaborating with experts to prepare products validated for science and practical use cases.
Market contenders can offer customization options like personalized support levels and custom-fit braces to meet individual needs effectively.
By focusing on streamlining the purchase process, like offering hassle-free returns and convenient online ordering options, players can build loyalty and trust among their target market.
Recent Developments
In October 2023, OrthoPediatrics Corp. launched the DF2 Brace as a strategy to expand into non-surgical business to treat kids suffering from musculoskeletal injuries.
In September 2023, Enovis Corporation officially disclosed the acquisition of LimaCorporate S.p.A. The acquisition of the latter company added a wide variety of orthopedic medical devices like braces and other support apparatus.
Key Players in the Orthopedic Braces and Support Industry:
DJO, LLC (United States)
Zimmer Biomet (United States
Medtronic (Ireland)
Stryker Corporation (United States)
Össur (Iceland)
NuVasive®, Inc (United States)
Integra LifeSciences Corporation (United States)
Globus Medical (United States)
OTTOBOCK (Germany)
AC Mould Engineering Limited (China)
Johnson and Johnson Services, Inc (United States)
Weber Orthopedic LP. DBA Hely and Webe (United States)
BSN medical (India)
Becker Orthopedic (United States)
OPPO MEDICAL INC (United States)
Langer Biomechanics (United States)
Frank Stubbs Company Inc. (United States)
DeRoyal Industries, Inc (United States)
Ascent Meditech Limited (India)
Alcare Co., Ltd (Tokyo)
Others
Orthopedic Braces and Support Industry by Category:
By Product:
Braces and Supports Type
Knee Braces for Osteoarthritis and Ligament Injuries
Post-operational Knee Braces
Upper Spine Orthoses
TLSOs
LSOs
Soft Braces
Hinged Braces
Pneumatic
Non-pneumatic
Elbow Braces and Supports
Wrist Braces and Supports
Pain Management Products
Cold Therapy Products
DVT Products
By End-user:
Orthopedic Clinics
Over the Counter (OTC)
Hospitals
DME Dealers
Others
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia and the Pacific
East Asia
Middle East and Africa
Orthopedic Braces and Support Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Global Tip Location Device Market : A Deep Dive into Key Drivers and Trends
The global tip location devices market, critical tools for ensuring accurate catheter placement during medical procedures... View MoreGlobal Tip Location Device Market : A Deep Dive into Key Drivers and Trends
The global tip location devices market, critical tools for ensuring accurate catheter placement during medical procedures, is anticipated to reach US$357.7 million by 2034. This signifies a steady growth trajectory with a compound annual growth rate (CAGR) of 4.2% from 2024, driven by the increasing demand for real-time monitoring and streamlined procedures.
Tip location devices play a crucial role in medical procedures by providing accurate feedback on catheter tip placement, minimizing the need for additional imaging techniques such as X-rays. This not only reduces radiation exposure for patients but also streamlines procedures for healthcare providers, leading to improved patient outcomes and operational efficiency.
Lead With Intelligence: Report Sample Awaits:
https://www.futuremarketinsights.com/reports/sample/rep-gb-880
Several factors are contributing to the market’s expansion:
Focus on Procedural Efficiency and Patient Safety: Healthcare providers are increasingly seeking technologies that streamline procedures and minimize complications. Tip location devices offer real-time visualization of catheter placement, reducing the need for fluoroscopy (X-ray imaging) and associated radiation exposure.
Demand for Point-of-Care Monitoring: The ability to continuously monitor catheter position at the point of care allows for immediate intervention in case of dislodgement, improving patient outcomes.
Advancements in Imaging Technologies: Companies are actively investing in research and development of advanced imaging technologies for tip location devices. This includes the development of infusion therapy devices with features that provide real-time, accurate information about catheter tip placement.
The Battle for Market Dominance: Key Players Making Strategic Moves in the Tip Location Devices Industry
The Tip Location Devices industry is highly competitive, with a large number of established players as well as new entrants vying for market share. Some of the key players operating in the market include C. R. Bard, Inc., Teleflex Incorporated, AngioDynamics, Inc., Cognate Bioservices, Inc., B. Braun Melsungen AG, Integra LifeSciences Corporation, VYGON, and Intravenous Medications, Inc.
These companies are constantly innovating and introducing new products to stay competitive in the market. They are also focusing on strategic partnerships and collaborations with other industry players to expand their product portfolios and reach new markets.
The market is also characterized by a high degree of fragmentation, with numerous small and medium-sized players operating in various regional markets. These players often specialize in specific product categories or geographical regions and compete based on price, quality, and innovation.
In addition to traditional medical device companies, there are also several startups and emerging players in the market, many of which are focused on developing innovative and disruptive technologies. These companies often focus on niche areas of the market, such as wearable Tip Location Devices, or ultrasound-based systems for catheter placement.
More Insights Available:
North America and Europe are the major markets for vascular access devices, owing to the presence of advanced healthcare infrastructure, high healthcare expenditure, and the increasing prevalence of chronic diseases. Moreover, the high adoption rate of innovative medical devices and favorable reimbursement policies are also driving the growth of the vascular access devices market in these regions.
Competitive Landscape of the Tip Location Device Market:
Leading businesses are strategically partnering and broadening their geographic reach in order to bolster their positions. These businesses want to have a revolutionary effect on the tip positioning devices market by offering increased precision in less invasive treatments. Important market participants are expanding geographically in order to reach a wider audience and seize new opportunities.
Recent Developments in the Tip Location Device Market
In May 2023, Teleflex Incorporated launched two groundbreaking devices set to transform PICC insertion procedures. The Arrow® VPS Rhythm® DLX device and NaviCurve™ Stylet together bring a new level of efficiency and predictability for vascular access specialists.
In June 2023, BD inaugurated a state-of-the-art research and development center in Dublin, investing around US$ 4.32 million. It also announced plans to allocate a further approximately US$ 32.41 million to improve its manufacturing facility in Enniscorthy, Ireland.
Key Segments:
By Product:
Tip Location System
Accessories
ECG Cables
ECG Clip Cables
ECG Lead Set
By Technology:
ECG Tip Confirmation
ECG with Magnetic Tracking
ECG and IV Doppler
By End User:
Hospitals
Ambulatory Surgical Centers (ASCS)
Catheterization Labs
Tip Location Device Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Unlocking Potential: How Technology is Transforming the Global Preterm Birth Prevention and Management Market
The global preterm birth prevention and management market solutions are poised for sig... View MoreUnlocking Potential: How Technology is Transforming the Global Preterm Birth Prevention and Management Market
The global preterm birth prevention and management market solutions are poised for significant growth in the coming decade, with a projected value of US$ 4.49 billion by 2034. This remarkable rise represents a compound annual growth rate (CAGR) of 10.2%, fueled by an increased focus on preventing and managing this critical public health concern.
Preterm birth, defined as birth before 37 weeks of gestation, is a leading cause of newborn mortality and disability, posing significant challenges to healthcare systems worldwide. Recognizing the substantial impact of preterm birth, both developed and developing nations are increasingly adopting advanced therapeutics and strategies for prevention and management.
Lead With Intelligence: Report Sample Awaits:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6457
Key Takeaways of the Study
Development of higher complexity specific portfolios and consistent focus on areas of strength while working pipelines are the cornerstone for success in the preterm birth prevention market space.
Ensuring preterm interventions and research given proportional focus, so funding is aligned with health burden to curb the mortality rate
Makena, with various approvals for the treatment of preterm birth in potential female patient pool, contributed to the dominance of the progesterone therapy segment by therapy type in 2018 and continue to do so during the forecast period.
Highly effective therapies with cost advantage over are expected to generate significant revenue in the long run.
Majority of the global preterm birth cases have not been directed towards preterm diagnostic leading to higher mortality rates and complications
Sale of Hydroxyprogesterone over antihypertensive drugs such as Nifedipine, and labetalol in the global preterm birth prevention and management market has increased drastically owing to quicker onset of action and higher efficacy.
The demand from high preterm birth rate countries, development of new drug entity, loss of exclusivity in hydroxyprogesterone, and growth strategies based on tie up with distribution channel partners are projected to offer new growth opportunities for the preterm birth prevention and management market.
Launch of Cost-effective Therapies Bodes Well for Market
New revenue opportunities in developed economies, and orphan drug designation by FDA are contributing significantly towards the launch of cost-effective therapies. A few other factors assisting the growth of preterm birth prevention and management market include adoption of preterm diagnostic tests and the economic burden of premature birth on the system.
Frequent drug shortages and unavailability of life-saving formulations in many parts of the country, growing initiatives by government and manufacturers for supply of life-saving preterm birth drugs, particularly in low income and developing countries, are driving the market growth.
Strategic Acquisitions by Key Players to Widen Regional Presence
The leading players in the preterm birth prevention and management market such as AMAG Pharmaceuticals, Pfizer Inc., and Mylan, are concentrating on organic revenue growth and commercial expansions by mergers and distribution agreements and capturing the untapped potential of the preterm birth prevention and management market.
In 2022, AMAG Pharmaceuticals, Inc. a largest preterm birth prevention and management drug manufacturer announced the completion of acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical firm. With the acquisition, AMAG received ciraparantag to its development portfolio. This acquisition further strengthened AMAG Pharmaceuticals hold of preterm birth prevention and management business with addition of heparin therapy
AMAG acquired the global rights to R&D and marketing of digoxin immune Fab, a drug used to treat severe preeclampsia in pregnant women from Velo Bio, LLC.
More Valuable Insights on Preterm birth prevention and management Market
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The global preterm birth prevention and management market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/6457
Preterm Birth Prevention and Management Market by Category
By Therapy Type:
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Heparin Prophylaxis Therapy
Low-Dose Aspirin Therapy
Antibiotics Therapy
By Route of Administration:
Oral
Parenteral
Vaginal
By Patient Type:
Prior Spontaneous PTB
Preeclampsia
Short Cervix
Chronic Hypertension
Insulin-dependent
Twins
Antiphospholipid Antibody Syndrome
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
By Region:
North America
Europe
Latin America
South Asia
East Asia
Oceania
Middle East and Africa
Preterm Birth Prevention and Management Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Global Focus on Improved Outcomes: Global Preterm Birth Diagnostic Test Kits Market
The global preterm birth diagnostic test kits market, which recorded sales of $121.3 million in 2021, is poised fo... View MoreGlobal Focus on Improved Outcomes: Global Preterm Birth Diagnostic Test Kits Market
The global preterm birth diagnostic test kits market, which recorded sales of $121.3 million in 2021, is poised for significant growth, with sales expected to reach US$ 203.2 million by 2028. Over the forecast period of 2022–2028, the market is projected to grow at a compound annual growth rate (CAGR) of 7.6%.
Preterm birth, a leading cause of neonatal mortality and morbidity worldwide, necessitates early detection and intervention to mitigate adverse outcomes. The demand for preterm birth diagnostic test kits is on the rise, driven by the pressing need to identify high-risk pregnancies and implement timely interventions.
Lead With Intelligence: Report Sample Awaits:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7551
Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market:
According to the data, the number of births in 2017 was roughly 115.4 million, of which 12.8 million or 11.1% were preterm. Preterm birth problems are the biggest cause of death for children under the age of five, according to the World Health Organization. In 2015, they were directly responsible for around one million deaths. Of these, cost-effective measures can avoid three-quarters of these deaths. Across different regions, preterm birth diagnostic test kit adoption rates varied from 2% to 15%. A substantial chunk of the preterm birth test kit market has gone untapped, leaving it open for manufacturers of preterm diagnostic test kits. This is because the majority of the current patient pool is ignorant of the cost-saving advantages of preterm birth diagnostic test kits.
Analysis of the Preterm Birth Diagnostic Test Kits Market:
The most common sample used for preterm labor and premature membrane rupture diagnosis in preterm birth diagnostic test kits is blood. The most popular and widely recognized preterm birth diagnostic test kits among end users are those that employ blood samples for preterm birth diagnosis. On the other hand, preterm birth diagnostic test kits using vaginal discharge sample type are becoming more and more common.
Patients experiencing symptoms of preterm birth are primarily referred to hospitals, outpatient clinics, and diagnostic laboratories that use preterm birth diagnostic tests. Because they are the principal healthcare institution for preterm cases, hospitals are expected to account for the majority of the revenue share under the end users segment for the preterm birth diagnostic test kits market in 2017.
Preterm Birth Diagnostic Test Kits Market – Competitive Landscape:
The key players of this market are adopting strategies such as product launch, acquisition, partnership and collaborations to gain expand their market presence and open up new streams of revenue generation.
In June 2021, Medix Biochemica announced the launch of a new molecular diagnostic reagents division named “MedixMDx” to offer extensive range of products and services for their customers.
In September 2020, QIAGEN announced the acquisition of NeuMoDx Molecular Inc., which helped the company to complete their product portfolio of PCR technology based automated molecular testing solutions.
In May 2021, Sera Prognostics announced a strategic commercial partnership with Anthem Inc., to make their “PreTRM® “tests available to all the customers of Anthem in the U.S.
Since the awareness of preterm birth diagnostic test kits is increasing, the demand for these kits will rise in the next few years. This creates many lucrative opportunities for the key players of this industry.
Key Companies Profiled:
Qiagen
Medix Biochemica
Hologic Inc.
Sera Prognostics
IQ Products
Creative Diagnostics
Nanjing Liming Biological Preparations Co., Ltd.
Clinical Innovations, LLC
Bioserv Diagnostic GmbH
Preterm Birth Diagnostic Test Kits Market, By Category:
Product:
ffN Test
PAMG-1 Test
IGFBP-1 Test
Sample:
Blood
Urine
Vaginal Discharge
End User:
Hospitals
Diagnostic Laboratories
Outpatient Clinics
Research Centers
Region:
North America
Latin America
Western Europe
Eastern Europe
Middle-East & Africa
APECJ
China
Japan
Preterm Birth Diagnostic Test Kits Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
A Brighter Future for Autism Care: Global COPD Therapeutics Market
The global COPD therapeutics market is expected to grow steadily, reaching a predicted value of US$20,035.5 million by 2033. A co... View MoreA Brighter Future for Autism Care: Global COPD Therapeutics Market
The global COPD therapeutics market is expected to grow steadily, reaching a predicted value of US$20,035.5 million by 2033. A compound annual growth rate (CAGR) of 5.1% from its market value of US$12,144.1 million in 2023 is seen in this noteworthy increase.
The respiratory symptoms of chronic obstructive pulmonary disease (COPD), which include cough, sputum production, and dyspnea, are accompanied by a restriction in airflow. A multimodal strategy including medication interventions, lifestyle changes, pulmonary rehabilitation, and patient education is necessary for the effective management of COPD.
Airflow restriction and chronic respiratory symptoms are hallmarks of COPD, a progressive lung illness mostly brought on by smoking, environmental toxins, and genetic predisposition. Effective treatments are essential for treating symptoms, preventing exacerbations, and enhancing patient quality of life, as COPD is a major global public health burden.
Several important aspects are responsible for the expected rise in the global market for COPD treatments. The need for efficient treatment alternatives is being driven by the rising rates of COPD, especially in older populations, as well as rising tobacco use and air pollution. Furthermore, new treatments for COPD patients are being made possible by developments in pharmaceutical research and development, such as the introduction of targeted biologics and innovative therapeutics.
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4337
Surgical Procedures for Serious Instances:
Surgery might be advised in COPD instances that are very severe. Treatment options include lung volume reduction surgery, lung transplants, and bullectomies. To stop the disease’s progression and enhance patient outcomes, appropriate therapeutic care is crucial, as evidenced by the high prevalence of COPD.
Combination Therapies Are Becoming More PopularThe market for COPD treatments is seeing an increase in patients’ preference for combination treatments over single prescriptions, or monotherapy. LABA-ICS (long-acting beta antagonist and inhaled corticosteroid) and LAMA-ICS (long-acting muscarinic antagonist and inhaled corticosteroid) are two examples of combination therapy that have the following benefits:Enhanced Effectiveness: When it comes to controlling COPD symptoms and raising patients’ quality of life, combination treatments work better than monotherapy.
Better Patient Outcomes: Combination medications provide a more successful treatment strategy for patients who do not respond well to bronchodilators or corticosteroids alone, which may increase demand for COPD therapeutics.
Key players:
Pfizer Inc.
Adamis Laboratories Inc.
GlaxoSmithKline plc.
AstraZeneca
Merk & Co.
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Key Segments Profiled in the COPD Therapeutics Industry Survey
By Component:
COPD Therapeutics Drug Class
Bronchodilators
Steroids
Phosphodiesterase-4 inhibitors
Theophylline
Antibiotics
COPD Therapeutics Delivery Systems
Oral
Inhalation
By End User:
Hospitals
Private Clinics
Outpatient Departments
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
COPD Therapeutics Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Meeting the Needs of a Growing Population: The Evolving Global Chronic Disease Management Market
The global chronic disease management market is expected to grow significantly, reaching a value of... View MoreMeeting the Needs of a Growing Population: The Evolving Global Chronic Disease Management Market
The global chronic disease management market is expected to grow significantly, reaching a value of US$16.83 billion by 2033. From its estimated value of US$4.77 billion in 2023, this extraordinary increase reflects a powerful Compound Annual Growth Rate (CAGR) of 13.4%.
Global healthcare systems are heavily burdened by chronic diseases, which include diabetes, cancer, heart disease, respiratory conditions, and mental health issues. Preventing the advancement of chronic diseases, minimizing complications, and enhancing patient outcomes necessitate the use of effective management measures.
A number of important variables are responsible for the chronic illness management market’s expected expansion throughout the world. The need for efficient management solutions is being driven by the rising incidence of chronic diseases, which are being caused by aging populations, sedentary lifestyles, and unhealthy eating habits. Furthermore, the way chronic disease treatment is delivered is being revolutionized by advances in healthcare technologies like wearables, telemedicine, and health monitoring platforms. These innovations allow for remote monitoring, individualized interventions, and better patient interaction.
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5370
Stakeholders are realizing more and more the value of proactive management and preventative care programs as healthcare systems throughout the world struggle to address the issues presented by chronic diseases. Healthcare providers, payers, and technology vendors may improve patient outcomes, reduce the burden of disease, and increase delivery efficiencies by investing in creative solutions and collaborative care models.
Managing Compensation: Enhancing Treatment Cost-Effectiveness:
Providers of chronic illness management are essential in helping patients understand the intricacies of medical reimbursement. To guarantee that patients may access reasonably priced treatment alternatives and make claims for their entitlement benefits, this also includes instructions on Medicare and Medicaid.
Competitive Landscape
In order to deliver patient-centric care, leading service providers in this market are concentrating on teamwork and partnerships with healthcare stakeholders. This is leading to the emergence of new trends in the chronic illness management industry For example:
In November 2021, IBM launched Imaging AI orchestration to help imaging organizations experience the benefits of AI applications working seamlessly together.
HealthSmart Holdings, Inc. has offered fully integrated and highly comprehensive care management solutions and services. These solutions manage members with chronic diseases to avoid future health risks.
Allscripts Healthcare Solutions, Inc., has its Villa Medical Center which is a patient-centered primary care home, reaching out to patients with chronic illnesses.
Key Players Profiled in the Market:
TriZetto Corporation
IBM
Pegasystems Inc.
EXL Healthcare
AxisPoint Health
Wellcentive, Inc.
Medecision, Inc.
i2i Systems, Inc.
HealthSmart Holdings, Inc.
Allscripts Healthcare Solutions, Inc.
ZeOmega Inc.
Epic Corporation Inc.
Harmony Information Systems, Inc.
Key Segments Covered:
Chronic Disease Management Market by Service Type:
Consulting Services
Implementation Services
Educational Services
Other
By Delivery Mode:
On-premise
Web-based
Cloud-based
By End User:
Providers
Payers
Key Regions Covered:
North America
The United States
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
Germany
The United Kingdom
France
Spain
Russia
Rest of Europe
Japan
Asia Pacific Excluding Japan
China
India
Malaysia
Singapore
Australia
Rest of Asia Pacific Excluding Japan (APEJ)
The Middle East and Africa
GCC Countries
Israel
South Africa
The Middle East and Africa (MEA)
Chronic Disease Management Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Global Focus on Improved Outcomes: Global Handheld Arthroscopic Instruments Market
The global handheld arthroscopic instruments market for handheld arthroscopic instruments will grow steadily, reac... View MoreGlobal Focus on Improved Outcomes: Global Handheld Arthroscopic Instruments Market
The global handheld arthroscopic instruments market for handheld arthroscopic instruments will grow steadily, reaching a valuation of US$5.2 billion by 2033. This is a substantial rise from its projected value of US$3.3 billion in 2023, when a strong 4.7% Compound Annual Growth Rate (CAGR) was predicted over the duration of the prediction.
In minimally invasive orthopedic operations, handheld arthroscopic instruments are essential because they allow surgeons to precisely visualize and treat joint-related disorders with the least amount of tissue damage. These instruments include a variety of specialized tools that are necessary for performing arthroscopic procedures, such as probes, shavers, graspers, and arthroscopes.
Deepen Understanding With Your Sample Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-6001
The market for handheld arthroscopic equipment is expected to rise due to the increasing incidence of sports injuries and musculoskeletal problems, as well as the growing use of minimally invasive surgical methods. The demand for cutting-edge handheld devices is being driven by healthcare professionals’ increased use of arthroscopy operations in response to patients’ desire for less intrusive treatment choices with faster recovery times.
Benefits of Arthroscopy
When compared to conventional open operations, arthroscopic techniques have various benefits. Patients who undergo minimally invasive procedures usually experience shorter recovery periods and less discomfort following surgery. As a result, many patients and surgeons prefer arthroscopy since it allows for a quicker return to regular daily activities.
The Future of Arthroscopy
The arthroscopic surgical scene is constantly changing, as seen by the growing requirement for sophisticated hand devices. We may anticipate more developments in instrument functionality and design as the market grows. This opens the door for a future in which arthroscopy plays an increasingly important role in the diagnosis and treatment of joint problems, especially when combined with the inherent advantages of minimally invasive treatments.
Market Competition:
Among the leading companies in the worldwide market for portable arthroscopic instruments are Tornier N.V., Zimmer Biomet, Arthrex, Smith & Nephew, Karl Storz, and Stryker.
Because the major players are present, the market is quite competitive. Global giants like Stryker, Karl Storz, and Smith & Nephew represent a sizeable portion of the market, while a number of regional businesses are also active in important growing areas, most notably Asia Pacific.
In June 2022 – Stryker announced the opening of its new research and development facility, Stryker’s Global Technology Centre (SGTC), at the International Tech Park, Gurgaon. The facility is estimated to help accelerate innovation in India and globally and further support the company’s mission to improve healthcare.
In May 2022, Karl Storz inaugurated the construction of the new production buildings Take Off (TO) 85 and 87 in Germany. With this project, the company intends to widen its manufacturing capabilities in the Tuttlingen region, paving the way for ultra-modern workplaces. The expansion project is also estimated to enhance the company’s capacity to produce arthroscopic instruments, among other product offerings.
Handheld Arthroscopic Instruments Market by Segmentation:
By Product Type:
Knives
Graspers
Scissors
Others
By Application:
For Knee Surgery
For Shoulder Surgery
For Hip Surgery
For Others
By End User:
For Hospitals
For Ambulatory surgical centers (ASCs)
For Specialty Clinics
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East & Africa (MEA)
Handheld Arthroscopic Instruments Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Beyond Diagnosis: Exploring Global Hospital Workforce Management Market
The global hospital workforce management market is expected to grow significantly, reaching a projected value of US$4,209.5 mi... View MoreBeyond Diagnosis: Exploring Global Hospital Workforce Management Market
The global hospital workforce management market is expected to grow significantly, reaching a projected value of US$4,209.5 million by 2033. Its strong Compound Annual Growth Rate (CAGR) of 10.6% from its projected value of US$1,533.2 million in 2023 is reflected in this notable surge.
To ensure optimal staffing levels, streamlined workflows, and improved patient care delivery, hospitals and other healthcare facilities must practice efficient workforce management. Hospital workforce management solutions comprise various software and services intended to enhance workforce productivity and satisfaction, optimize resource allocation, and automate scheduling.
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4390
Hospital workforce management solutions are essential for improving patient care delivery, streamlining operations, and optimizing staffing levels in healthcare facilities. These solutions cover a wide range of tools and techniques, such as workforce analytics, time and attendance monitoring, and scheduling, all geared toward effectively managing healthcare staff.
Many important factors are responsible for the expected growth in the global hospital workforce management market. The adoption of advanced workforce management solutions is being driven by the growing need for improved patient care outcomes as well as the necessity of hospital efficiency and cost-effectiveness. In order to improve overall operational efficiency, hospitals and other healthcare facilities are realizing more and more how important it is to optimize staffing levels, minimize administrative burdens, and guarantee regulatory compliance.
Leading Players in Hospital Workforce Management Market:
The industry is dominated by a number of companies, including IBM Corporation, Atoss Software, McKesson Corporation, GE Healthcare, Kronos, Inc., SAP AG, Infor, Inc., Automatic Data Processing, Inc., Cornerstone On-demand, Inc., and Ultimate Software Group, Inc. The focus among the players is on offering distinctive product experiences in order to attract a larger clientele. In addition, various expansion tactics like joint ventures to fortify supply chains, acquisitions, and distribution networks are also utilized.
In October 2021, Microsoft announced the launch of a new health IT tool to assist healthcare administrators in frontline workforce management because of better overall healthcare metrics.
GE Healthcare, one of the pioneers in the hospital workforce management domain, offers a wide range of services, from digital solutions, which include asset performance and clinical performance management, to healthcare technology management, site planning, and interoperability.
SAP offers the Workforce Suite for Healthcare, which is effectively used as a SaaS solution and can be integrated with SAP Cloud using standard SAP-approved interfaces and APIs. In addition, the interface achieves operational performance levels of 99.5%
Key Segments Covered in the Hospital Workforce Management Industry Report
By Product Type:
Standalone Software
Time and Attendance
HR and Payroll
Scheduling
Talent Management
Analytics
Others
Integrated Software
By Service:
Implementation Services
Support and Maintenance
Optimization Services
Training/Education Services
By Mode of Delivery:
Web-based
Cloud-based
On-premise
By Region:
North America Market
Latin America Market
Europe Market
East Asia Market
South Asia and Pacific Market
The Middle East & Africa Market
Hospital Workforce Management Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
Unveiling the Power of Data: Global Direct-to-Consumer Genetic Testing Market
The global direct-to-consumer genetic testing market growth. As per Future Market Insights, the market is anticipated t... View MoreUnveiling the Power of Data: Global Direct-to-Consumer Genetic Testing Market
The global direct-to-consumer genetic testing market growth. As per Future Market Insights, the market is anticipated to expand at a wonderful Compound Annual Growth Rate (CAGR) of 11.4% from its projected value of US$1,645.5 million in 2023 to an astounding US$4,843.4 million by 2033.
The way people obtain genetic information about their ancestry, physical traits, and possible health risks has been completely transformed by direct-to-consumer (DTC) genetic testing. Through commercial genetic testing firms, consumers can acquire genetic information directly without going through a healthcare professional intermediary. These tests usually use saliva or cheek swabs to analyze a person’s DNA and reveal details on their genetic makeup, ancestry,
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15137
The anticipated growth of the global direct-to-consumer genetic testing market has several causes. Thanks to advancements in data analytics and DNA sequencing technology, as well as the rising price of genetic testing kits, genetic testing is becoming more accessible and user-friendly. The increasing consumer knowledge of the benefits of proactive health management and individualized treatment is also driving the need for genetic information to inform lifestyle choices, illness prevention strategies, and healthcare decisions.
Competitive Landscape:
Some of the prominent players in the global market are-
23andMe
Ancestry DNA
Color Genomics, Inc.
Genetic Technology (EasyDNA)
Full Genomes Corporation, Inc.
Helix OpCo LLC
IDENTIGENE, LLC/ DNA Diagnostics Center
Living DNA Ltd
MyHeritage Ltd
Prenetics Limited
Family Tree DNA
Interleukin Genetics/orig3n
Counsyl/Myriad Genetics, Inc.
Veritas Genetics
Fulgent Genomics
Some of the recent industry developments in the global direct-to-consumer genetic testing market are:
In January 2022, 23andMe Holding Co., a leading consumer genetics and research company, received FDA clearance for a genetic health risk report on a hereditary prostate cancer marker.
In August 2021, Ancestry, a global leader in family history, announced that it has agreed to acquire Geneanet, a renowned French genealogy company. With over 30 billion records from more than 80 countries, Ancestry helps customers discover new details about their family stories and ancestors.
In June 2023, Prenetics Global Limited, a leading genomics and precision oncology company, announced financial results for the first quarter ending March 31, 2023, along with recent business updates.
Direct-to-Consumer Genetic Testing Market Outlook by Category
By Product:
Pharmacogenetics Tests
Carrier Screening Tests
Genetic Health Risk (GHR) Tests
Cancer Predisposition Tests
Low-Risk General Wellness Tests
Ancestry Tests
By Technology:
Single Nucleotide Polymorphism Chip
Whole Genome Sequencing
By Sample:
Saliva
Urine
Blood
By Sales Channel:
Institutional Sales
Hospitals
Specialty Clinics
Diagnostic Laboratories
Others
Retail Sales
Retail Pharmacies
Online Sales
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
Middle East and Africa
Direct-to-Consumer Genetic Testing Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
A Market on the Move:Exploring Investment Opportunities in Global Mobile Operating Rooms Market
The global mobile operating rooms market is expected to increase rapidly and reach US$1301.8 million... View MoreA Market on the Move:Exploring Investment Opportunities in Global Mobile Operating Rooms Market
The global mobile operating rooms market is expected to increase rapidly and reach US$1301.8 million by 2033. According to Future Market Insights, this increase is indicative of a 3.9% Compound Annual Growth Rate (CAGR), exceeding the market’s estimated size of US$889.9 million in 2023.
Because they provide flexible, fully-equipped surgical facilities that may be deployed in a variety of settings, such as military operations, disaster relief efforts, and distant or underserved locations, mobile operating rooms are essential to the delivery of healthcare services. These portable devices, which come with cutting-edge surgical instruments, anesthetic systems, and sterilizing technologies, let medical professionals carry out a variety of surgical procedures in a safe and efficient manner.
Deepen Understanding With Your Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5534
The expected growth of the global market for mobile operating rooms presents significant opportunities for manufacturers of medical equipment, healthcare facilities, and governments to enhance surgical capacity, improve patient outcomes, and strengthen healthcare infrastructure worldwide.
Competitive Landscape:
Some of the prominent players working in the global market are-
Kentucky Trailer
MedCoach
Mobile Healthcare Facilities LLC
Stryker
Odulair LLC.
AMoHS, Inc
Mobile Medical International Corporation
EMS Mobil Sistemler
Cerner Corporation
McKesson Corporation
Recent Developments by the Leading Players in the Market
In December 2016, Methodist Center for Diagnostic Imaging (CDI) was opened in the United States of America to deliver high-quality and cost-effective medical imaging to patients.
In January 2017, Envision Healthcare merged with AmSurg Corp. and acquired Emergency Professional Services.
In April 2020, the Centers for Medicare & Medicaid Services (CMS) announced recommendations for postponing non-essential surgeries and other procedures in collaboration with medical societies and associations.
In December 2020, T.H. Medical announced the acquisition of 45 ambulatory surgery centers from SurgCenter, a key developer of physician-owned centers.
In April 2021, HCA Healthcare announced plans to open a new multi-specialty ASC, Willis Surgery Center, by 2022.
In November 2022, California-based Adventist Health Mendocino Coast (AHMC) announced a US$ 12 million Oracle Cerner EHR implementation that is expected to increase interoperability across the Adventist Health Network.
Key Segments:
By Type:
Hospital Affiliated ASCs
Freestanding ASCs
By Service:
Diagnostic Service
Surgical Service
By Sales Channel:
Retail
Brand Stores
E-Commerce
By Region:
North America
Latin America
Asia Pacific
The Middle East and Africa
Europe
Mobile Operating Rooms Market - Sample | Future Market Insights
Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
page=1&profile_user_id=61836&year=&month=
Load More
